All supplements

Supplement evidence

169 / 575Research index — evidence review pending

Anatabine

View my plan

The short answer

No use has passed JIVANA's study-level evidence review yet.

Evidence and scope
Research gathered — evidence review pending

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
No efficacy conclusion has passed JIVANA's study-level review yet. The linked research index is for discovery, not a benefit claim.
Before deciding
Identity, dose, interactions, product quality, and regulatory status still require review. Do not use this provisional page to decide whether to take it.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

Study-level extraction is not complete yet.

This research-index page is live so the topic, source trail, and evidence boundaries are visible. Individual studies have not yet passed the JIVANA extraction and review process, so we do not manufacture an efficacy conclusion or research count from broad search results.

Unscreened discovery appendix—not evidence7 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial.Benowitz NL, Hu J, Luo X et al. · 2026 · Addiction (Abingdon, England) · PMID 41852246Open on PubMed
  2. Multiple Pharmacotherapy Adaptations for Smoking Cessation Based on Treatment Response in Black Adults Who Smoke: A Randomized Clinical Trial.Nollen NL, Ahluwalia JS, Mayo MS et al. · 2023 · JAMA network open · PMID 37338906Open on PubMed
  3. Effects of anatabine and unilateral maximal eccentric isokinetic muscle actions on serum markers of muscle damage and inflammation.Jenkins ND, Housh TJ, Cochrane KC et al. · 2014 · European journal of pharmacology · PMID 24509134Open on PubMed
  4. Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trial.Schmeltz LR, Blevins TC, Aronoff SL et al. · 2014 · The Journal of clinical endocrinology and metabolism · PMID 24178792Open on PubMed
  5. Parent quit attempts after counseling to reduce children's secondhand smoke exposure and promote cessation: main and moderating relationships.Liles S, Hovell MF, Matt GE et al. · 2009 · Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · PMID 19875763Open on PubMed
  6. A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.Murphy SE, Link CA, Jensen J et al. · 2004 · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · PMID 15466978Open on PubMed
  7. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy.Jacob P 3rd, Hatsukami D, Severson H et al. · 2002 · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · PMID 12496059Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.